Focus Partners Wealth

Position in LLY — ELI LILLY & Co

CIK 1542153 ST LOUIS, MO

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$311,905,800

+$93,805,339 QoQ

Shares Held

260,045

+9.7% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#206

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 48% Shared 4% None 48%

Healthcare · as of Jun 30, 2026

Focus Partners Wealth holds $1,442,065,327 across 15 Drug Manufacturers - General names. LLY ranks #2 (21.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,488,289	$377,980,757
2	LLY	ELI LILLY & Co This page	260,045	$311,905,800
3	ABBV	AbbVie Inc.	929,566	$233,915,988
4	MRK	Merck & Co., Inc.	1,375,512	$176,753,292
5	AMGN	Amgen Inc	315,585	$114,279,640
6	PFE	Pfizer Inc	2,693,994	$64,871,375
7	GILD	Gilead Sciences, Inc.	475,579	$60,084,650
8	NVS	Novartis AG	235,657	$36,932,165

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$311,905,800	260,045	+9.7%	Shares	Sole	2026-08-12
2026-03-31	$218,100,461	237,125	+6.7%	Shares	Sole	2026-05-15
2025-12-31	$238,839,054	222,242	+35.6%	Shares	Sole	2026-02-13
2025-09-30	$125,072,486	163,922	+8.4%	Shares	Sole	2025-11-14
2025-06-30	$117,886,762	151,228	+22.3%	Shares	Sole	2025-08-14
2025-03-31	$102,111,382	123,635	+4.8%	Shares	Sole	2025-05-20
2024-12-31	$91,069,752	117,966	+63.9%	Shares	Sole	2025-05-20
2024-09-30	$63,756,672	71,965	-43.1%	Shares	Sole	2024-11-14
2024-06-30	$114,450,896	126,412	+170.2%	Shares	Sole	2024-08-15
2024-03-31	$36,401,526	46,791	+48.2%	Shares	Sole	2024-05-16
2023-12-31	$18,401,035	31,567	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.